Hem Securities has initiated a buy rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 1340 in its April 16, 2009 research report. “GlaxoSmithKline Pharmaceuticals has registered good set of numbers for the quarter ended December 2008. …
Buy GSK Pharma, target of Rs 1340: Hem Securities
Posted on: April 19th 2009 in Brokerage Recommendations.
Latest Query
- by Sam
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis